鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/06 | 3,700 | 3,750 | 3,665 | 3,720 | +60 | +1.6% | 32,000 |
| 2023/12/05 | 3,675 | 3,720 | 3,655 | 3,660 | -60 | -1.6% | 18,500 |
| 2023/12/04 | 3,725 | 3,730 | 3,635 | 3,720 | -30 | -0.8% | 39,700 |
| 2023/12/01 | 3,705 | 3,760 | 3,700 | 3,750 | +90 | +2.5% | 72,100 |
| 2023/11/30 | 3,650 | 3,720 | 3,570 | 3,660 | +10 | +0.3% | 100,300 |
| 2023/11/29 | 3,660 | 3,665 | 3,635 | 3,650 | ±0 | ±0% | 16,900 |
| 2023/11/28 | 3,595 | 3,655 | 3,570 | 3,650 | +85 | +2.4% | 49,400 |
| 2023/11/27 | 3,635 | 3,635 | 3,535 | 3,565 | -80 | -2.2% | 36,600 |
| 2023/11/24 | 3,665 | 3,665 | 3,640 | 3,645 | -15 | -0.4% | 14,500 |
| 2023/11/22 | 3,600 | 3,660 | 3,595 | 3,660 | +80 | +2.2% | 30,500 |
| 2023/11/21 | 3,600 | 3,630 | 3,560 | 3,580 | -35 | -1% | 21,700 |
| 2023/11/20 | 3,640 | 3,645 | 3,605 | 3,615 | -20 | -0.6% | 16,800 |
| 2023/11/17 | 3,610 | 3,645 | 3,580 | 3,635 | +25 | +0.7% | 31,000 |
| 2023/11/16 | 3,580 | 3,645 | 3,550 | 3,610 | +55 | +1.5% | 35,400 |
| 2023/11/15 | 3,545 | 3,575 | 3,535 | 3,555 | +10 | +0.3% | 22,000 |
| 2023/11/14 | 3,610 | 3,610 | 3,545 | 3,545 | -45 | -1.3% | 17,400 |
| 2023/11/13 | 3,650 | 3,650 | 3,580 | 3,590 | -55 | -1.5% | 14,200 |
| 2023/11/10 | 3,605 | 3,650 | 3,590 | 3,645 | +65 | +1.8% | 24,900 |
| 2023/11/09 | 3,595 | 3,595 | 3,555 | 3,580 | -15 | -0.4% | 12,500 |
| 2023/11/08 | 3,605 | 3,625 | 3,560 | 3,595 | -20 | -0.6% | 27,700 |
| 2023/11/07 | 3,625 | 3,665 | 3,595 | 3,615 | -10 | -0.3% | 30,800 |
| 2023/11/06 | 3,630 | 3,680 | 3,620 | 3,625 | +15 | +0.4% | 41,500 |
| 2023/11/02 | 3,580 | 3,610 | 3,550 | 3,610 | +85 | +2.4% | 48,200 |
| 2023/11/01 | 3,570 | 3,630 | 3,485 | 3,525 | -115 | -3.2% | 61,800 |
| 2023/10/31 | 3,600 | 3,640 | 3,545 | 3,640 | +85 | +2.4% | 56,500 |
| 2023/10/30 | 3,665 | 3,665 | 3,530 | 3,555 | -105 | -2.9% | 41,800 |
| 2023/10/27 | 3,635 | 3,660 | 3,610 | 3,660 | +10 | +0.3% | 20,800 |
| 2023/10/26 | 3,710 | 3,720 | 3,620 | 3,650 | -50 | -1.4% | 31,500 |
| 2023/10/25 | 3,730 | 3,760 | 3,695 | 3,700 | -15 | -0.4% | 50,100 |
| 2023/10/24 | 3,785 | 3,790 | 3,645 | 3,715 | -80 | -2.1% | 67,000 |
| 2023/10/23 | 3,875 | 3,875 | 3,785 | 3,795 | -55 | -1.4% | 47,900 |
| 2023/10/20 | 3,870 | 3,885 | 3,830 | 3,850 | ±0 | ±0% | 17,300 |
| 2023/10/19 | 3,905 | 3,905 | 3,815 | 3,850 | -55 | -1.4% | 23,000 |
| 2023/10/18 | 3,910 | 3,925 | 3,870 | 3,905 | +5 | +0.1% | 31,200 |
| 2023/10/17 | 3,900 | 3,930 | 3,860 | 3,900 | +35 | +0.9% | 22,800 |
| 2023/10/16 | 3,870 | 3,900 | 3,835 | 3,865 | -10 | -0.3% | 36,000 |
| 2023/10/13 | 3,900 | 3,945 | 3,855 | 3,875 | -35 | -0.9% | 37,400 |
| 2023/10/12 | 3,815 | 3,925 | 3,815 | 3,910 | +100 | +2.6% | 28,300 |
| 2023/10/11 | 3,860 | 3,875 | 3,810 | 3,810 | -60 | -1.6% | 32,700 |
| 2023/10/10 | 3,875 | 3,890 | 3,780 | 3,870 | +180 | +4.9% | 76,300 |
| 2023/10/06 | 3,660 | 3,725 | 3,655 | 3,690 | +35 | +1% | 22,000 |
| 2023/10/05 | 3,570 | 3,660 | 3,570 | 3,655 | +55 | +1.5% | 35,100 |
| 2023/10/04 | 3,650 | 3,680 | 3,580 | 3,600 | -90 | -2.4% | 70,400 |
| 2023/10/03 | 3,800 | 3,805 | 3,680 | 3,690 | -115 | -3% | 47,800 |
| 2023/10/02 | 3,930 | 3,935 | 3,805 | 3,805 | -65 | -1.7% | 19,300 |
| 2023/09/29 | 3,960 | 3,960 | 3,865 | 3,870 | -90 | -2.3% | 36,700 |
| 2023/09/28 | 3,950 | 3,985 | 3,920 | 3,960 | +10 | +0.3% | 52,400 |
| 2023/09/27 | 3,900 | 3,980 | 3,865 | 3,950 | +30 | +0.8% | 51,300 |
| 2023/09/26 | 3,875 | 3,935 | 3,865 | 3,920 | -5 | -0.1% | 15,300 |
| 2023/09/25 | 3,855 | 3,935 | 3,850 | 3,925 | +110 | +2.9% | 29,500 |
101～
150
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 401,000円 | +7.3% | +16.8% | 2.99% | 23.99倍 | 0.94倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 持田薬 | 322,500円 | -1.2% | -37.3% | 2.48% | 25.98倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 183,200円 | +2.6% | +11.5% | 2.84% | 21.48倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 211,300円 | +6.8% | +18.7% | 2.08% | 13.31倍 | 1.23倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 80,100円 | +32.2% | +84.6% | 2.50% | 13.70倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
